Quipt Home Medical Taken Private in Kingswood Acquisition
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Quipt Home Medical ( (TSE:QIPT) ) has issued an update.
On March 16, 2026, Quipt Home Medical completed a plan of arrangement under British Columbia law whereby 1567208 B.C. Ltd., funded in part by affiliates of Kingswood Capital Management and Forager Capital Management, acquired all outstanding Quipt shares for US$3.65 in cash per share, valuing the transaction at about US$173 million and taking the company private. As part of the deal, all options and restricted share units were cashed out or cancelled, Quipt is being delisted from Nasdaq and the Toronto Stock Exchange and intends to terminate its public reporting obligations in the U.S. and Canada, while its board and executive ranks were reconstituted with new directors backed by Kingswood and Forager and CEO Gregory Crawford remaining in place to lead the company’s next phase as a private, growth-focused respiratory care platform.
The most recent analyst rating on (TSE:QIPT) stock is a Hold with a C$5.00 price target. To see the full list of analyst forecasts on Quipt Home Medical stock, see the TSE:QIPT Stock Forecast page.
Spark’s Take on QIPT Stock
According to Spark, TipRanks’ AI Analyst, QIPT is a Neutral.
The score is driven by mixed fundamentals: strong revenue growth and positive free cash flow support the profile, but ongoing losses, negative ROE, and moderate-to-elevated leverage meaningfully cap the rating. Technicals are supportive with an uptrend versus key moving averages, while valuation is penalized because earnings are negative and there is no dividend yield data.
To see Spark’s full report on QIPT stock, click here.
More about Quipt Home Medical
Quipt Home Medical Corp. is a U.S.-based provider of home medical equipment and in-home monitoring services, specializing in end-to-end respiratory care within the U.S. healthcare market. The company focuses on managing chronic disease states, including heart and pulmonary disease, sleep disorders, reduced mobility, and other long-term conditions, aiming to broaden its range of in-home monitoring and disease management services.
Average Trading Volume: 40,303
Technical Sentiment Signal: Hold
Current Market Cap: C$222.3M
For detailed information about QIPT stock, go to TipRanks’ Stock Analysis page.
